People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Pharmaceuticals, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $478.3M | $8.3B | 2020 |
| PAIGE.AI, Inc. | — | AI / ML | Series C | $145.5M | $316.4M | 2021 |
R. Martin Chavez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. Martin Chavez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Thomas Kelly | 1 | 9 |
| Jeffrey Lightcap | 1 | 5 |
| Robert Galvin | 1 | 5 |
| Kenan Turnacioglu | 1 | 4 |
| Alex Robertson | 1 | 3 |
| Perry Fell | 1 | 3 |
| Jim Breyer | 1 | 3 |
| H. PERRY FELL | 1 | 2 |
| David Castelblanco | 1 | 2 |
| Norman Selby | 1 | 2 |
| DEAN C. LI | 1 | 1 |
| ZAVAIN PERRY DAR | 1 | 1 |
| REID PERRY HUTCHINS | 1 | 1 |
| Dean Li | 1 | 1 |
| Dean Y. Yi | 1 | 1 |
| Jeffrey Andrew Lightcap | 1 | 1 |
| Blake Borgeson | 1 | 1 |
| DEAN Y. LI | 1 | 1 |
| Christopher Gibson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.